<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
	<channel>
		
		<title>Bardehle Pagenberg</title>
		<link>http://www.bardehle.com/</link>
		<description>News of Bardehle Pagenberg</description>
		<language>en</language>
		<image>
			<title>Bardehle Pagenberg</title>
			<url>http://www.bardehle.com/fileadmin/img/Bardehle_Pagenberg_icon.jpg</url>
			<link>http://www.bardehle.com/</link>
			<width>75</width>
			<height>75</height>
			<description>News of Bardehle Pagenberg</description>
		</image>
		<generator>TYPO3 - get.content.right</generator>
		<docs>http://blogs.law.harvard.edu/tech/rss</docs>
		
		
		
		<lastBuildDate>Wed, 22 Feb 2012 12:44:00 +0100</lastBuildDate>
		
		
		<item>
			<title>German Parliament proposes bill: no patentability of farm animals and agricultural crops (in German)</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/german-parliament-proposes-bill-no-patentability-of-farm-animals-and-agricultural-crops-in-german.html</link>
			<description>Am 17. Januar 2012 haben die Fraktionen CDU/CSU, SPD, FDP und Bündnis 90/die Grünen eine gemeinsame...</description>
			<content:encoded><![CDATA[Am 17. Januar 2012 haben die Fraktionen CDU/CSU, SPD, FDP und Bündnis 90/die Grünen eine gemeinsame Vorlage (Drucksache 17/8344) &nbsp;in den Bundestag eingebracht. Diese sieht vor, konventionell gezüchtete landwirtschaftliche Nutztiere und Nutzpflanzen von der Patentierbarkeit auszuschließen. 
<b>Die weltweite Bedeutung der grünen Biotechnologie </b>
Die Bedeutung der globalen grünen Biotechnologie ist sehr groß. So werden 148 Mio. ha weltweit für den Anbau gentechnisch veränderter Pflanzen verwendet. Während in den USA und Asien große Mengen dieser Pflanzen hergestellt und verkauft werden, nimmt ihre Akzeptanz&nbsp; in einigen Ländern Europas, insbesondere in Deutschland weiter ab. Ein Ausweg aus dieser Problematik ist das Forschen nach verbesserten nicht-gentechnisch veränderten Pflanzen. Neben der konventionellen Züchtung wird hier auf die effizientere Marker-unterstützte Züchtung gesetzt. Wie bei konventionellen Züchtungsverfahren wird nach Pflanzen mit erwünschten Eigenschaften durch Kreuzung und Selektion gesucht. Durch molekulare Marker werden die durch Kreuzung erzeugten Pflanzen schneller und genauer selektioniert. Die Marker befinden sich nach der Selektion nicht in den Pflanzen, so dass die erzeugten &nbsp;Pflanzen nicht gentechnisch verändert sind.&nbsp; &nbsp;
<b>Die aktuelle Patentpraxis</b>
Die EU-Biotechnologie-Richtlinie 98/44 hat das Ziel, den rechtlichen Schutz biotechnologischer Erfindungen zu stärken. Sie wurde 2005 in deutsches Recht umgesetzt. Die Richtlinie wurde ferner von der Europäischen Patentorganisation in das Europäische Patentübereinkommen (EPÜ) implementiert. Nach der Richtlinie und dem angepassten deutschen und europäischen Patentrecht können Erfindungen auf Tiere und Pflanzen patentiert werden, sofern die technische Lehre der Erfindung nicht auf eine bestimmte Tierrasse oder Pflanzensorte beschränkt ist, die von der Patentierbarkeit explizit ausgenommen sind. Die Begründung für den Ausschluss von Pflanzensorten besteht darin, dass durch den Sortenschutz ein komplementäres Schutzrecht verfügbar ist und ein Doppelschutz nicht erforderlich ist. Für Tierrassen gibt es kein solches komplementäres Schutzrecht. 
Das Deutsche und das Europäische Patentamt erteilen auf der Grundlage des geltenden Rechts Patente auf Erfindungen, die Pflanzen und Tiere betreffen. 
<b>Die Vorlage</b>
Ausgangspunkt der Vorlage ist die Bestimmung Art. 53b), 2. Alt. EPÜ, nach der im Wesentlichen biologische Verfahren zur Züchtung von Pflanzen oder Tiere ausgeschlossen sind. In ihren Entscheidungen vom 9. Dezember 2010 hat die Große Beschwerdekammer des EPA im „Tomaten“ bzw. „Brokkoli“-Fall entschieden, wann ein Verfahren ein im wesentlichen biologisches Verfahren darstellt, das von der Patentierbarkeit ausgeschlossen ist. 
Die Autoren der Vorlage argumentieren nun, dass Art. 53b) EPÜ, der nur Verfahren zur Züchtung von Pflanzen und Tieren von der Patentierbarkeit ausschließt, konsequenterweise auch Pflanzen und Tiere ausnehmen sollte, die durch solche Verfahren erhalten wurden. 
<b>Das geltende Patentgesetz schützt die Pflanzenzüchter</b>
Das deutsche und europäische Patentamt erteilen Patente auf Erfindungen, die neu sind, auf einer erfinderischen Tätigkeit beruhen und gewerblich anwendbar sind. 
Erfindungen, die Tiere bzw. Pflanzen betreffen, werden daher erteilt, wenn diese Tiere bzw. Pflanzen nicht „naheliegend“ sind, insbesondere weil sie gegenüber vorbekannten Pflanzen und Tieren unerwartete vorteilhafte Eigenschaften aufweisen. Der Erfinder leistet daher einen Beitrag, den andere nutzen können (aber nicht nutzen müssen) und erhält dafür ein Patent, das ihm zeitlich begrenzte Ausschließlichkeitsrechte gewährt. 
Sofern es sich um gentechnisch veränderte Tiere oder Pflanzen handelt, wird diese Praxis von den Gegnern auch nicht in Zweifel gezogen, sondern die Vorlage betrifft allein den Fall, dass die landwirtschaftlichen Nutztiere oder Nutzpflanzen über konventionelle Züchtungsverfahren erhalten wurden. Auch wenn ein bekanntes Verfahren angewendet wird, schließt dies nicht aus, dass patentfähige Produkte erhalten werden, die neue vorteilhafte Eigenschaften aufweisen. 
Beispielsweise war lange bekannt, dass durch Bestrahlung die Eigenschaften von Bakterien verändert werden können. Wenn jetzt bekannte Bakterien bestrahlt werden und hierdurch ein neues Bakterium entsteht, das sich von den bekannten in nicht naheliegender Weise unterscheidet, weil es besondere vorteilhafte Eigenschaften aufweist, so ist das Bakterium patentfähig. Es ist nicht zu erkennen, warum dem Erfinder, der konventionelle Züchtungsverfahren anwendet, die „Belohnung“, d.h. die Patenterteilung versagt werden sollte. Dies gilt insbesondere wenn die Züchtung zu einem Nutztier führt, das nicht wie Nutzpflanzen durch ein anderes Schutzrecht wie den Sortenschutz geschützt werden kann. 
Die Gegner einer Patentierung von Pflanzen und Tieren argumentieren, dass der Ausschluss von Verfahren zur Züchtung von Tieren und Pflanzen in das Patentgesetz aufgenommen wurde, um konventionelle Tier- und Pflanzenzüchter nicht zu behindern. Dieser Zweck wird, wie nachfolgend ausgeführt, auch dann erreicht, wenn die bisherige Praxis der Patentierung beibehalten wird. 
Das deutsche Patentgesetz sieht vor, dass die Nutzung einer patentierten Pflanze zum Zweck der Züchtung einer neuen Pflanzensorte keine Patentverletzung darstellt (§ 11 Nr. 2a PatG). Das Patentgesetz trägt daher den Bedenken der Pflanzenzüchter bereits ausreichend Rechnung.&nbsp; 
Anders ist die Situation bei Tierzüchtern. Die Verwendung eines patentgeschützten Nutztiers zu Zwecken der Züchtung stellt eine Patentverletzung dar. Würde man die Patentierbarkeit von Nutztieren ausschließen, wäre nicht nur die Verwendung zu Zuchtzwecken frei, sondern auch jede weitere Verwendung zu gewerblichen Zwecken, so dass derjenige, der ein neues Tier gezüchtet hat, ohne Schutzrechte dastehen würde. Jeder Anreiz für eine gewerbliche Züchtung von neuen Nutztieren würde dadurch entfallen. 
Das deutsche Patentgesetz schränkt den Patenschutz auf Nutztiere jedoch durch das sogenannte Landwirte-Privileg ein. Dem Patentinhaber steht das Recht auf die 1. Generation von Nutztieren und Nutzpflanzen zu. Sofern die Vermehrung dieser 1. Generation nicht zu gewerblichen Zwecken erfolgt, sondern nur zur Führung der Landwirtschaft dient, fallen nachfolgende Generationen nicht unter den Patentschutz. &nbsp;&nbsp;
Das bestehende Patentgesetz berücksichtigt daher die Interessen der Pflanzenzüchter und der Landwirte und schränkt den Patentschutz ein. Ein weitergehender Ausschluss von Nutztieren und Nutzpflanzen, die durch konventionelle Züchtungsverfahren erhalten werden, würde den wirtschaftlichen Anreiz zur Forschung nach neuen Pflanzen und Tieren beseitigen. 
Es sei darauf hingewiesen, dass in dem „Tomaten“-Fall (EP1211926B1) die Verfahrensansprüche gestrichen wurden, jedoch Ansprüche auf die durch das konventionelle Züchtungsverfahren erhaltenen Tomaten beibehalten wurden. Die Einsprechende hat eine nochmalige Befassung der Großen Beschwerdekammer des EPA mit dieser Sache gefordert. Es bleibt also spannend. &nbsp;

Dr. Thomas Friede, Patentanwalt, BARDEHLE PAGENBERG, München
]]></content:encoded>
			<category>Gewerbliche Rechtschutz Infos</category>
			
			
			<pubDate>Wed, 22 Feb 2012 12:32:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>Dusseldorf Appeal Court grants protection against imitation of a rear light for trucks</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/dusseldorf-district-court-grants-protection-against-imitation-of-a-rear-light-for-trucks.html</link>
			<description>In a decision which has just become final, the Dusseldorf Appeal Court granted protection against...</description>
			<content:encoded><![CDATA[In a decision which has just become final, the Dusseldorf Appeal Court granted protection against distributing a replica of a rear light for trucks (Case No I-20 U 68/10). &nbsp;The matter related to a quasi-identical imitation of a rear light for trucks which Vignal Systems SA, a French-based automotive supply company and one of the internationally leading manufacturers of signal lamps for automobiles, had originally developed at the end of the nineties and since then distributed also in Germany. &nbsp;The original rear light was not protected by a design or patent in Germany. &nbsp;The Dusseldorf District Court and Dusseldorf Appeal Court, however, both found the reproduction to be an unlawful imitation under German unfair competition law.
The defendant, Nicolaos Dasteridis SA, argued that the accused rear light was a spare part, the form and appearance of which were predetermined by the original, and that the allegation of it being an unlawful imitation was invalidated by a different sign of the manufacturer attached onto the light.
Earlier, the Hamburg District Court had held that the rear light of Nicolaos Dasteridis SA did not infringe the rights of Vignal Systems SA. &nbsp;Also earlier, a claim by Vignal Systems SA for a preliminary injunction prohibiting the accused rear light had been rejected by the Hamburg Appeal Court (in these proceedings, the Vignal SA had not yet been represented by BARDEHLE PAGENBERG).
In spite of these negative decisions, the Dusseldorf Appeal Court granted protection against the challenged rear light in main proceedings initiated by BARDEHLE PAGENBERG on behalf of Vignal Systems SA. &nbsp;The Court found that the outer appearance of the original rear light showed competitive individuality so that consumers would perceive the product as stemming from a specific company. &nbsp;Distribution of an identical reproduction, thus, would lead to a likelihood of confusion as to origin.&nbsp; Such likelihood would not be excluded by using the – insufficiently visible – sign of Nicolaos Dasteridis SA on the accused rear light.
The defendant’s appeal against refusal of leave to appeal was dismissed by the German Federal Supreme Court on December 21, 2011 (Case No I ZR 25/11), thus rendering the decision of the Dusseldorf Appeal Court final. &nbsp;This established German case law shows: Protection may be granted against imitation not only if a product is protected by patent, design or copyright law, but also if its design factually distinguishes it from the field of competing products.
Representatives Vignal Systems SA: 
<b>BARDEHLE PAGENBERG</b> (Munich): Dr. Stefan Abel (Attorney-at-Law, Partner), Pascal Böhner (Attorney-at-Law, Certified IP Lawyer)
Representatives Nicolaos Dasteridis SA:
<b>Von Huebner</b> (Munich): Dominik von Huebner (Attorney-at-Law)
<b>Dusseldorf Appeal Court (20. Civil Senate)</b>
Professor Wilhelm Berneke (Presiding Judge)]]></content:encoded>
			<category>Kanzleinews</category>
			
			
			<pubDate>Thu, 02 Feb 2012 17:08:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>German Federal Supreme Court strengthens position of foreign-language patent applicants</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/-4d57006473.html</link>
			<description>Mistakes in the German translation of a patent application filed in a foreign language can be...</description>
			<content:encoded><![CDATA[Mistakes in the German translation of a patent application filed in a foreign language can be corrected anytime and do not lead to loss of the patent.
At the German Patent and Trademark Office (GPTO) patent applications can be filed that are not composed in the German language. The applicant thus safeguards the filing date for the technical disclosure content of his foreign-language application. However, a German translation must be filed within three months after the filing of the foreign-language application which then becomes the basis of further examination procedure. In the present case, the Federal Supreme Court decided on the consequences which omissions and mistakes in the German translation may trigger.
In the case to be decided by the Federal Supreme Court the GPTO had ruled that a foreign-language patent application was to be taken as not filed if later, after the three months period, the translation showed any omissions. The omissions became manifest in that only 12 of the 26 claims of the foreign-language application were entirely translated. The legal fiction of the non-filed application – that is the denial of the filing date – is provided for by the law (Section 35 (2), p. 2 German Patent Act) in case of a translation not duly filed within the deadline. The GPTO had therefore equated a faulty translation with a missing translation.
In its decision of July 18, 2011 – X ZB 10/10 – the Federal Supreme Court found that such conduct was contrary to the spirit and purpose of the law, since by Section 35 German Patent Act the non-German applicant was explicitly given the possibility to safeguard the disclosure content of his foreign-language application. The foreign applicant should not be forced to file <i>a priori</i> in the German language, because in this case, he would expose himself to the danger of losing technical disclosure content which could be missing later, if the case may be, for delimitation vis-à-vis the prior art. On the other hand, it would not make sense to first give the possibility to the applicant to safeguard his filing date for his foreign-language application, and to then deny that filing date if the subsequently filed translation is faulty.
The Federal Supreme Court does not find the minimal requirements for the translation to be higher than the foreign-language application itself. These minimal requirements are: the name of the applicant, an application for grant and – at least the appearance of – a description. The law does not require any patent claims for the granting of an application date. If the above preconditions for a translation are fulfilled, the legal fiction of the non-existent application does not apply, which means that in the concrete case the claims missing in the translation did not trigger the legal consequence of the loss of the application date.
The decision is very welcome since it clarifies that mistakes in the translation of patent applications not filed in the German language are not legally detrimental. Such mistakes do not lead to loss of the application date and can be corrected at any time during the application proceedings. From an attorney’s point of view, the decision is also to be evaluated very positively. If the Federal Supreme Court had decided that mistakes in the patent applications may indeed lead to a loss of the application date, the German representative of the applicant would be exposed to substantive liability risks. He would have the choice to either file the foreign-language application of his client as it is, and to file a translation later, or to file a German translation directly. The first alternative would involve the risk that a subsequently filed faulty translation may lead to a loss of the application date. The second alternative entails the risk to lose technical disclosure content which may later be missing, as the case may be, for delimitation against the prior art.]]></content:encoded>
			<category>Gewerbliche Rechtschutz Infos</category>
			
			
			<pubDate>Thu, 02 Feb 2012 12:04:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>IP Report 2011/V</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/ip-report-2011v.html</link>
			<description>The current edition of our newsletter features the latest developments in IP Law.
Download IP...</description>
			<content:encoded><![CDATA[The current edition of our newsletter features the latest developments in IP Law.
<link fileadmin/contentdocuments/ip_reports/IP_Report_2011_V.pdf - download>Download IP Report 2011/V</link>
This IP Report is also available in an online version. <link http://www.bardehle.com/en/publications/search_in_all_publications/document/ip-report-2011v.html - external-link-new-window>Click here</link>.]]></content:encoded>
			<category>Kanzleinews</category>
			<category>Home Featured News</category>
			
			
			<pubDate>Mon, 19 Dec 2011 17:54:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>Cologne Appeal Court: BARDEHLE PAGENBERG again successful in design infringement proceedings regarding “Veneers”</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/cologne-appeal-court-bardehle-pagenberg-again-successful-in-design-infringement-proceedings-regardi.html</link>
			<description>The Swiss-based Coltène/Whaledent AG, an internationally leading developer, manufacturer and...</description>
			<content:encoded><![CDATA[The Swiss-based Coltène/Whaledent AG, an internationally leading developer, manufacturer and distributer of dental-medical consumer goods and small-sized devices, had successfully sued Edelweiss Dentistry Products GmbH, Austria, for Community design infringement. The subject matter of the three asserted and accused designs was the representation of so-called “Veneers”. These are extremely thin and light-transparent screen shells which are applied to the dental surface, primarily at the front teeth.
The Cologne Appeal Court had granted claims for design infringement <i>ex parte</i> and issued a preliminary injunction which, after first appeal of Edelweiss, was confirmed by judgment of June 29, 2011 (Case No. 84 O 69/11). The Cologne Appeal Court recently followed the assessment of the lower instance and also found validity and infringement of the Community designs (decision of November 25, 2011 – Case No. 6 U 155/11).
The Cologne Appeal Court held that it was not decisive how the asserted designs had been developed, but whether the result of this process produced a different overall impression compared with another, earlier design. In the case at hand, the prior art submitted by Edelweiss, however, was not detrimental to novelty and individual character of the asserted designs; the corresponding evidence was deemed to be inappropriate. The Cologne Appeal Court also found infringement as the asserted and accused designs produced the same overall impression, while minimal differences “receded into the realm of the imperceptible”.
Representatives Coltène/Whaledent AG:
<b>BARDEHLE PAGENBERG</b> (Munich): Dr. Henning Hartwig (Attorney-at-law, partner)
Representatives Edelweiss Dentistry Products GmbH:
<b>Hofstetter, Schurack &amp; Skora</b> (Munich): Dr. Patrick Baronikians (Attorney-at-law)
Cologne Appeal Court (6th Civil Senate):
<b>Hubertus Nolte</b> (Presiding Judge)]]></content:encoded>
			<category>Kanzleinews</category>
			
			
			<pubDate>Wed, 14 Dec 2011 17:12:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>ECJ rules on validity and infringement test under European design law</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/ecj-rules-on-validity-and-infringement-test-under-european-design-law-in-re-pepsico-v-ohim-1.html</link>
			<description>Court of Justice of the European Union on the validity and infringement test under European design...</description>
			<content:encoded><![CDATA[<b>Court of Justice of the European Union on the validity and infringement test under European design law (decision of October 20, 2011 – Case C-281/10 P – PepsiCo v Office for Harmonisation in the Internal Market – Grupo Promer)</b>
On October 20, 2011, the Court of Justice of the European Union, Europe’s final authority on Community design law, rendered its long-awaited decision in <i>PepsiCo v OHIM</i> (Case C-281/10 P) with the central issue being the manner in which differences or similarities between conflicting designs are established under the Community Design Regulation (“CDR”). The underlying products were small metal plates, also referred to as “rappers”, playthings inserted in product packages, and the validity of the Community design was challenged to be “in conflict with”, <i>i.e.</i>, to infringe an earlier Spanish design.
The proceedings before the Court of Justice focused on four legal questions (a fifth question related to an alleged distortion of the facts is not part of this review), namely whether the lower instance, the General Court of the European Union, committed any errors in relation to (i) the constraints on the designer’s freedom (Article 10 [2] CDR), (ii) the concept of the informed user and his level of attention (Article 10 [1] CDR), (iii) the scope of the General Court’s power of review (Article 61 [2] CDR), and (iv) whether it was possible to compare the underlying goods rather than the conflicting designs (Article 10 [1] CDR).
(i) Starting with possible constraints limiting the degree of freedom of the designer in developing the design, the Court of Justice found that assessing such constraints would relate to findings of a factual nature made by the General Court rather than to any legal questions. In fact, PepsiCo did not challenge the facts as being distorted and neither disputed the relevance of the criteria for establishing the designer’s degree of freedom (<i>inter alia</i>, the constraints of the features imposed by the technical function of the product or an element thereof or by statutory requirements applicable to the product). Thus, the Court of Justice, in accordance with settled case law, held the challenge of that assessment as inadmissible.
(ii) Turning to the concept of the informed user and his level of attention, this concept, according to the Court of Justice, first “must be understood as lying somewhere between that of the average consumer, applicable in trademark matters, who need not have any specific knowledge and who, as a rule, makes no direct comparison between the trade marks in conflict, and the sectoral expert, who is an expert with detailed technical expertise.” Consequently and second, such concept had to be understood as “referring, not to a user of average attention, but to a particularly observant one, either because of his personal experience or his extensive knowledge of the sector in question.” Thus, the very nature of the informed user would mean that, when possible, he will make a direct comparison between the designs at issue. However, it cannot be ruled out that such a comparison may be impracticable or uncommon in the sector concerned, in particular because of specific circumstances or the characteristics of the devices which the designs at issue represent. Third and finally, as regards the informed user’s level of attention, the Court of Justice held that such user, without being a designer or a technical expert, would know “the various designs which exist in the sector concerned, possesses a certain degree of knowledge with regard to the features which those designs normally include, and, as a result of his interest in the products concerned, shows a relatively high degree of attention when he uses them.”
(iii) As regards the scope of the General Court’s power to review the Office’s examination of the differences and similarities between the designs at issue and its determination of whether or not there is a similar overall impression, the Court of Justice found that the in-depth examination of the designs at issue carried out by the General Court, contrary to the position also taken by the Office itself, did not go beyond its power to alter decisions under Article 61 CDR.
(iv) Lastly, and related to whether the Office or the General Court are allowed to base the assessment of the designs in conflict on a comparison of physical samples of actual products rather than only on the designs as disclosed and represented in the contested and in the earlier design registration, the Court of Justice found that such comparison was not mistaken, given that the informed user was different from the ordinary average consumer. The Court added that in the present case the physical comparison was done only to confirm the judgment already reached based on the respective registrations.]]></content:encoded>
			<category>Home Featured News</category>
			
			
			<pubDate>Fri, 28 Oct 2011 10:58:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>ECJ rules on validity and infringement test under European design law in re. PepsiCo v OHIM – Grupo Promer</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/ecj-rules-on-validity-and-infringement-test-under-european-design-law-in-re-pepsico-v-ohim.html</link>
			<description>Court of Justice of the European Union on the validity and infringement test under European design...</description>
			<content:encoded><![CDATA[<b>Court of Justice of the European Union on the validity and infringement test under European design law (decision of October 20, 2011 – Case C-281/10 P – PepsiCo v Office for Harmonisation in the Internal Market – Grupo Promer)</b>
On October 20, 2011, the Court of Justice of the European Union, Europe’s final authority on Community design law, rendered its long-awaited decision in <i>PepsiCo v OHIM</i> (Case C-281/10 P) with the central issue being the manner in which differences or similarities between conflicting designs are established under the Community Design Regulation (“CDR”). The underlying products were small metal plates, also referred to as “rappers”, playthings inserted in product packages, and the validity of the Community design was challenged to be “in conflict with”, <i>i.e.</i>, to infringe an earlier Spanish design.
The proceedings before the Court of Justice focused on four legal questions (a fifth question related to an alleged distortion of the facts is not part of this review), namely whether the lower instance, the General Court of the European Union, committed any errors in relation to (i) the constraints on the designer’s freedom (Article 10 [2] CDR), (ii) the concept of the informed user and his level of attention (Article 10 [1] CDR), (iii) the scope of the General Court’s power of review (Article 61 [2] CDR), and (iv) whether it was possible to compare the underlying goods rather than the conflicting designs (Article 10 [1] CDR).
(i)&nbsp; Starting with possible constraints limiting the degree of freedom of the designer in developing the design, the Court of Justice found that assessing such constraints would relate to findings of a factual nature made by the General Court rather than to any legal questions. In fact, PepsiCo did not challenge the facts as being distorted and neither disputed the relevance of the criteria for establishing the designer’s degree of freedom (<i>inter alia</i>, the constraints of the features imposed by the technical function of the product or an element thereof or by statutory requirements applicable to the product). Thus, the Court of Justice, in accordance with settled case law, held the challenge of that assessment as inadmissible.
(ii)&nbsp; Turning to the concept of the informed user and his level of attention, this concept, according to the Court of Justice, first “must be understood as lying somewhere between that of the average consumer, applicable in trademark matters, who need not have any specific knowledge and who, as a rule, makes no direct comparison between the trade marks in conflict, and the sectoral expert, who is an expert with detailed technical expertise.” Consequently and second, such concept had to be understood as “referring, not to a user of average attention, but to a particularly observant one, either because of his personal experience or his extensive knowledge of the sector in question.” Thus, the very nature of the informed user would mean that, when possible, he will make a direct comparison between the designs at issue. However, it cannot be ruled out that such a comparison may be impracticable or uncommon in the sector concerned, in particular because of specific circumstances or the characteristics of the devices which the designs at issue represent. Third and finally, as regards the informed user’s level of attention, the Court of Justice held that such user, without being a designer or a technical expert, would know “the various designs which exist in the sector concerned, possesses a certain degree of knowledge with regard to the features which those designs normally include, and, as a result of his interest in the products concerned, shows a relatively high degree of attention when he uses them.”
(iii)&nbsp; As regards the scope of the General Court’s power to review the Office’s examination of the differences and similarities between the designs at issue and its determination of whether or not there is a similar overall impression, the Court of Justice found that the in-depth examination of the designs at issue carried out by the General Court, contrary to the position also taken by the Office itself, did not go beyond its power to alter decisions under Article 61 CDR.
(iv)&nbsp; Lastly, and related to whether the Office or the General Court are allowed to base the assessment of the designs in conflict on a comparison of physical samples of actual products rather than only on the designs as disclosed and represented in the contested and in the earlier design registration, the Court of Justice found that such comparison was not mistaken, given that the informed user was different from the ordinary average consumer. The Court added that in the present case the physical comparison was done only to confirm the judgment already reached based on the respective registrations.]]></content:encoded>
			
			
			<pubDate>Thu, 27 Oct 2011 18:01:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>ECJ: Exclusion from patentability of all human embryonic stem cell-related inventions in Europe (Brüstle v Greenpeace)</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/ecj-exclusion-from-patentability-of-all-human-embryonic-stem-cell-related-inventions-in-europe-br.html</link>
			<description>In its ruling dated October 18, 2011 – (Case C-34/10) – the Court of Justice of the European Union...</description>
			<content:encoded><![CDATA[In its ruling dated October 18, 2011 – (Case C-34/10) – the Court of Justice of the European Union had to decide on a referral by the German Federal Supreme Court in a nullity appeal proceedings with respect to a patent of the stem cell researcher Professor Brüstle. The patent relates to neural precursor cells derived from embryonic stem cells, including stem cells produced from the blastocyst stage of human embryos (hES). The claims do not mention the use of embryos for producing the ES cells. As alternative sources stem cells are mentioned which are derived from unfertilized human egg cells, i.e., embryonic germ cells (EGC) and unfertilized eggs in which a cell nucleus from a mature cell has been implanted (“dolly method”). The nullity action against the patent was exclusively based on Section 2 (2) No. 3 German Patent Act which is identical to Art. 6 (2) lit c Biotech-Directive and stipulates that no patents shall be granted for inventions directed to the use of human embryos for industrial or commercial purposes. 
The ECJ ruled that the term “embryo” includes any human egg cell after fertilization and&nbsp;any non-fertilized human egg cell into which either a cell nucleus has been implanted or undergoing parthenogenesis. The ECJ did not decide on the question whether an hES as such represented an embryo (rather, this decision shall be left to the national courts of the Member States). “Industrial or commercial purposes” cover also scientific research and do not overcome the exclusion from patentability. The exclusion from patentability does not depend on the fact that the prior destruction of human embryos is not contained in the claims. Even if the destruction is not mentioned in the specification at all, exclusion from patentability applies. 
The decision of the ECJ does not distinguish between hES inventions which exclusively rely on the destruction of human embryos and hES inventions which can be carried out using hES cell lines. All of them are being excluded from patentability based on the ruling of the ECJ. Furthermore, the ECJ decision does not affect the patentability of iPS (induced pluripotency stem cells) cells which have ES-like pluripotency but which are derived from human reprogrammed adult cells.
The decision of the ECJ is especially unfortunate in view of the fact that this year the first clinical trials in Europe for a drug on the basis of hES cells have been approved for the company ACT. The decision may have a negative impact on future research in this field of technology since the research results can no longer be patent protected and the pharmaceutical industry will therefore have a reduced interest in funding hES research in Europe.]]></content:encoded>
			
			
			<pubDate>Thu, 20 Oct 2011 10:56:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>EPLAW on Draft Agreement for a Unified Patent Court</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/eplaw-on-draft-agreement-for-a-unified-patent-court.html</link>
			<description>The European Patent Lawyers Association (EPLAW), under its President Dr. Jochen Pagenberg, has...</description>
			<content:encoded><![CDATA[<b>Th</b><b>e Unified Patent Court - </b><b>EPLAW Resolution on the Draft Agreement</b> <b>13751/11 of September 2, 2011</b>
<b>Introduction</b>
The European Patent Lawyers Association (EPLAW), comprising lawyers with many years of experience in European patent litigation, has been following closely the preparatory work for and the legal discussions regarding the creation of a European patent court system, <link fileadmin/contentdocuments/articles/EPLAW_Resolution_on_United_Patent_Court_27.9.2011.pdf - download>more ...</link>]]></content:encoded>
			
			
			<pubDate>Wed, 28 Sep 2011 11:21:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>BARDEHLE PAGENBERG successfully intervenes at Cologne trade fair against a dozen imitations of the well-known Lafuma deck chair</title>
			<link>http://www.bardehle.com/no_cache/en/news/news_of_the_firm/release/article/bardehle-pagenberg-successfully-intervenes-at-cologne-trade-fair-against-a-dozen-imitations-of-the-w.html</link>
			<description>In an action lasting several days at this year’s SPOGA Fair in Cologne, BARDEHLE PAGENBERG...</description>
			<content:encoded><![CDATA[In an action lasting several days at this year’s SPOGA Fair in Cologne, BARDEHLE PAGENBERG intervened against numerous imitations of the well-known “RSX” deck chair of Lafuma S.A. In the course of the fair all detected unlawful infringements could be stopped. 13 exhibited imitations were removed from the booths and more than twenty different retailers stopped advertising the imitations in their catalogues.
On the basis of forensic information gathered before the start of the fair in early September 2011, eleven copies could be removed from different booths shortly after the fair’s opening. Legal steps had to be taken against two further exhibitors, and within 24 hours preliminary injunctions were obtained from the Cologne District Court. These were served on the same day onto the fair which led to the removal of the prohibited deck chairs from the exhibition stands. 
The success of this action rests in the detailed preparation and the optimized interrelation between investigative activities and the targeted application of legal instruments. For many years BARDEHLE PAGENBERG has been intervening proactively on fairs against manufacturers of copycats and product imitations. Trade fairs offer an opportunity to enforce technical and non-technical intellectual property rights directly on the spot, in particular against companies without residence in Germany – and before their products reach the market.
<b>BARDEHLE PAGENBERG</b> (München): Dr. Stefan Abel (Attorney-at-Law, Partner), Pascal Böhner (Attorney-at-Law) 
]]></content:encoded>
			<category>Kanzleinews</category>
			
			
			<pubDate>Mon, 19 Sep 2011 17:41:00 +0200</pubDate>
			
		</item>
		
	</channel>
</rss>
